Is REPH or DVY a better dividend investment in 2026?

REPH currently yields 95.69% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: REPH offers higher current income.

What is the dividend yield difference between REPH and DVY?

REPH has a forward dividend yield of 95.69% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 92.19 percentage points.

Home › Compare › REPH vs DVY

REPH vs DVY: Dividend Comparison 2026

REPH yields 95.69% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 REPH wins by $3.24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

REPH

● Live price

95.69%

Share price

$2.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.26M

Annual income

$1,067,397.24

Full REPH calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — REPH vs DVY

📍 REPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	REPH	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, REPH + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

REPH pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REPH

Annual income on $10K today (after 15% tax)

$8,133.97/yr

After 10yr DRIP, annual income (after tax)

$907,287.65/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, REPH beats the other by $906,915.54/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REPH + DVY for your $10,000?

REPH: 50%DVY: 50%

100% DVY50/50100% REPH

Portfolio after 10yr

$1.64M

Annual income

$533,917.51/yr

Blended yield

32.49%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on REPH right now

REPH

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-1.1

Piotroski

2/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REPH buys

DVY buys

No recent congressional trades found for REPH or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricREPHDVY

Forward yield	95.69% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3.26M	$25.1K ✓
Annual income after 10y	$1,067,397.24 ✓	$437.78
Total dividends collected	$2.90M	$4.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: REPH vs DVY ($10,000, DRIP)

Year	REPH Portfolio	REPH Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$20,269	$9,569.38	$11,050	$349.62	+$9.2K → REPH
2	$39,816	$18,127.60	$12,184	$361.04	+$27.6K → REPH
3	$75,882	$33,279.13	$13,409	$372.07	+$62.5K → REPH
4	$140,469	$59,275.00	$14,730	$382.68	+$125.7K → REPH
5	$252,850	$102,548.32	$16,154	$392.89	+$236.7K → REPH
6	$443,065	$172,515.34	$17,688	$402.69	+$425.4K → REPH
7	$756,599	$282,519.41	$19,338	$412.07	+$737.3K → REPH
8	$1,260,443	$450,881.99	$21,113	$421.04	+$1.24M → REPH
9	$2,050,673	$701,999.14	$23,020	$429.61	+$2.03M → REPH
10	$3,261,617	$1,067,397.24	$25,070	$437.78	+$3.24M → REPH

REPH vs DVY: Complete Analysis 2026

REPH — Stock

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Full REPH Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this REPH vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REPH vs SCHD REPH vs JEPI REPH vs O REPH vs KO REPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.